141 related articles for article (PubMed ID: 25270285)
1. A genetic variant (rs17251221) in the calcium-sensing receptor relates to hepatocellular carcinoma susceptibility and clinical outcome treated by transcatheter hepatic arterial chemoembolization (TACE) therapy.
Tang Q; Zhao Y; Wang Y; Wei M
Med Oncol; 2014 Nov; 31(11):267. PubMed ID: 25270285
[TBL] [Abstract][Full Text] [Related]
2. A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with breast cancer susceptibility and prognosis.
Li X; Kong X; Jiang L; Ma T; Yan S; Yuan C; Yang Q
Cell Physiol Biochem; 2014; 33(1):165-72. PubMed ID: 24481145
[TBL] [Abstract][Full Text] [Related]
3. A genetic polymorphism (rs17251221) in the calcium-sensing receptor is associated with ovarian cancer susceptibility.
Yan S; Yuan C; Yang Q; Li X; Yang N; Liu X; Dong R; Zhang X; Yuan Z; Zhang N; Kong B
Oncol Rep; 2015 Oct; 34(4):2151-5. PubMed ID: 26252839
[TBL] [Abstract][Full Text] [Related]
4. Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization.
Wang XC; Wang F; Quan QQ
Genet Test Mol Biomarkers; 2016 Apr; 20(4):176-84. PubMed ID: 26918371
[TBL] [Abstract][Full Text] [Related]
5. Genetic variations in IDH gene as prognosis predictors in TACE-treated hepatocellular carcinoma patients.
Zhang H; Guo X; Dai J; Wu Y; Ge N; Yang Y; Ji J; Zhang H
Med Oncol; 2014 Nov; 31(11):278. PubMed ID: 25355558
[TBL] [Abstract][Full Text] [Related]
6. Genetic polymorphism of calcium-sensing receptor in women with breast cancer.
Campos-Verdes LM; da Silva-Sampaio JP; Costa-Silva DR; de Oliveira VA; Junior AMC; Silva VC; Alencar AP; Campelo V; Lopes-Costa PV; Gebrim LH; da Silva BB
Med Oncol; 2018 Jan; 35(3):23. PubMed ID: 29387985
[TBL] [Abstract][Full Text] [Related]
7. A genetic polymorphism (rs17251221) in the calcium-sensing receptor gene (CASR) is associated with stone multiplicity in calcium nephrolithiasis.
Chou YH; Woon PY; Chen WC; Hsu YW; Chang JM; Hwang DY; Chiu YC; Kuo HC; Chang WP; Hou MF; Liu ME; Chang JG; Chang WC
PLoS One; 2011; 6(9):e25227. PubMed ID: 21966463
[TBL] [Abstract][Full Text] [Related]
8. IL-28B variant as a predictor in patients with advanced hepatocellular carcinoma treated with hepatic arterial infusion chemotherapy.
Terashima T; Honda M; Toyama T; Shimakami T; Shimizu R; Takatori H; Arai K; Kawaguchi K; Kitamura K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Kaneko S
J Gastroenterol Hepatol; 2020 Oct; 35(10):1813-1820. PubMed ID: 32180251
[TBL] [Abstract][Full Text] [Related]
9. A functional polymorphism in PER3 gene is associated with prognosis in hepatocellular carcinoma.
Zhao B; Lu J; Yin J; Liu H; Guo X; Yang Y; Ge N; Zhu Y; Zhang H; Xing J
Liver Int; 2012 Oct; 32(9):1451-9. PubMed ID: 22809120
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of immune checkpoint proteins PD-1 and TIM-3 are associated with survival of patients with hepatitis B virus-related hepatocellular carcinoma.
Li Z; Li N; Li F; Zhou Z; Sang J; Jin Z; Liu H; Han Q; Lv Y; Liu Z
Oncotarget; 2016 May; 7(18):26168-80. PubMed ID: 27034168
[TBL] [Abstract][Full Text] [Related]
11. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
Baghdadi I; Abu Ella K; El Shaaraway A; Elshayeb E; El-Rebey HS; El Hoseeny M; Naguib M; Nada A
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2047-2053. PubMed ID: 32711431
[TBL] [Abstract][Full Text] [Related]
12. Functional polymorphisms in the NPAS2 gene are associated with overall survival in transcatheter arterial chemoembolization-treated hepatocellular carcinoma patients.
Yuan P; Wang S; Zhou F; Wan S; Yang Y; Huang X; Zhang Z; Zhu Y; Zhang H; Xing J
Cancer Sci; 2014 Jul; 105(7):825-32. PubMed ID: 24754267
[TBL] [Abstract][Full Text] [Related]
13. Genetic variants in the KDR gene is associated with the prognosis of transarterial chemoembolization treated hepatocellular carcinoma.
Zheng YB; Huang JW; Zhan MX; Zhao W; Liu B; He X; Li Y; Hu BS; Lu LG
Tumour Biol; 2014 Nov; 35(11):11473-81. PubMed ID: 25123269
[TBL] [Abstract][Full Text] [Related]
14. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
15. A Case-Control Study on the Correlation Between Thymidylate Synthase Gene Polymorphisms and Raltitrexed Treatment Combined with Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Treatment.
Qi C; Gao H; Li S; Zong H; Hao H; Zhang L
Genet Test Mol Biomarkers; 2020 Mar; 24(3):156-164. PubMed ID: 32101052
[No Abstract] [Full Text] [Related]
16. The safety and efficacy of balloon-occluded transcatheter arterial chemoembolization for hepatocellular carcinoma refractory to conventional transcatheter arterial chemoembolization.
Kim PH; Gwon DI; Kim JW; Chu HH; Kim JH
Eur Radiol; 2020 Oct; 30(10):5650-5662. PubMed ID: 32409860
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA Gene Polymorphisms in Evaluating Therapeutic Efficacy After Transcatheter Arterial Chemoembolization for Primary Hepatocellular Carcinoma.
Qiu GP; Liu J
Genet Test Mol Biomarkers; 2016 Oct; 20(10):579-586. PubMed ID: 27525669
[TBL] [Abstract][Full Text] [Related]
18. Expression quantitative trait loci for PAX8 contributes to the prognosis of hepatocellular carcinoma.
Ma S; Yang J; Song C; Ge Z; Zhou J; Zhang G; Hu Z
PLoS One; 2017; 12(3):e0173700. PubMed ID: 28339471
[TBL] [Abstract][Full Text] [Related]
19. Association of MicroRNA 196a and 499 Polymorphisms with Development of Cirrhosis and Hepatocellular Carcinoma Post-HCV Infection in Egyptian Patients.
Fteah AM; Ahmed AI; Mosaad NA; Hassan MM; Mahmoud SH
Asian Pac J Cancer Prev; 2019 Nov; 20(11):3479-3485. PubMed ID: 31759375
[TBL] [Abstract][Full Text] [Related]
20. Hepatic artery infusion chemotherapy using mFOLFOX versus transarterial chemoembolization for massive unresectable hepatocellular carcinoma: a prospective non-randomized study.
He MK; Le Y; Li QJ; Yu ZS; Li SH; Wei W; Guo RP; Shi M
Chin J Cancer; 2017 Oct; 36(1):83. PubMed ID: 29061175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
